TNF and rheumatoid arthritis: Various therapeutic agents have been developed to block chemical signals or proteins involved in the inflammatory pathway in RA, e.g., TNF inhibitors (TNFi), IL-6 receptor inhibitors (IL-6Ri), Janus kinase inhibitors (JAKi), anti-CD20 drug and co-stimulation molecules (CD80/86) inhibitor.